Abstract:Aim Epidermal growth factor-containing fibulin-like extracellular matrix protein 1(EFEMP1) has been found to be involved in the occurrence and development of many cancers. The relationship between EFEMP1 and the development of hepatocellular carcinoma (HCC) and the molecular mechanism are not fully understood. Methods Real-time polymerase chain reaction (PCR) and tissue microarray were used to detect the expression of EFEMP1 in HCC cell lines and tissue. Methylation-specific PCR assay was used to measure the methylation level of EFEMP1 in HCC cell lines and tissue. To study the function of EFEMP1 on cell function, Huh7 and HepG2 were infected with lentiviral particles expressing EFEMP1. MTT assay and colony formation assay were used to examine the effect of EFEMP1 on cell proliferation. Annexin-VAPC/7-AAD double were used to detect the effect of EFEMP1 on cell apoptosis. To further detect the effect of EFEMP1 on the development of HCC in vivo, we performed the tumor formation experiment in nude mice. Gene chip was used to detect the expression profile of Huh7 and HepG2 overexpressing EFEMP1. To further screen out the differences, GO analysis and pathway analysis were performed. To study the effects of SEMA3B, specific siRNA was used to inhibit the expression of SEMA3B. Chi-squared test and rank sum test were used to analyze the relationship between EFEMP1 expression and HCC clinical characteristic. Results The study found that the expression of EFEMP1 was significantly decreased in HCC cell lines and HCC tissues. The expression level of EFEMP1 was related to the TNM (the extent of the tumor, the extent of spread to the lymph nodes, the presence of metastasis) stage and the prognosis of patients with HCC. The decrease of protein expression suggested that the patient prognosis was worse, and the protein level of EFEMP1 may be an independent factor in the prognosis of HCC patients. Promoter methylation may be one of the reasons for EFEMP1 inhibition. EFEMP1 could inhibit the proliferation of HCC cells and promoted the apoptosis of HCC cells to regulate the development of HCC. And EFEMP1 promoted the apoptosis of HCC cells mainly through the mitochondrial apoptosis pathway. EFEMP1 may inhibit the proliferation of HCC cells through the SEMA3B gene in the Axon guidance pathway. Conclusion In summary, our research revealed the regulation of EFEMP1 on cell proliferation and apoptosis in HCC. EFEMP1 may suppress the growth of HCC cells by promoting SEMA3B.

EFEMP2 is Upregulated in Gliomas and Promotes Glioma Cell Proliferation and Invasion.

PSMC2/E2F1 Axis Promotes the Development and Progression of Glioma

EFEMP2 Promotes Colon Cancer Cell Invasion and Growth Through the ERK1/2 Signaling Pathway.

EFEMP2 Suppresses the Invasion of Lung Cancer Cells by Inhibiting Epithelial-Mesenchymal Transition (EMT) and Down-Regulating MMPs

EFEMP2 upregulates PD-L1 expression via EGFR/ERK1/2/c-Jun signaling to promote the invasion of ovarian cancer cells

Overexpression of EPAC2 Reduces the Invasion of Glioma Cells Via MMP-2

MiR-338-5p suppresses proliferation, migration, invasion, and promote apoptosis of glioblastoma cells by directly targeting EFEMP1.

Expression of elongation factor-2 kinase contributes to anoikis resistance and invasion of human glioma cells

EFEMP1 Promotes the Migration and Invasion of Osteosarcoma Via MMP-2 with Induction by AEG-1 Via NF-κB Signaling Pathway.

Epidermal Growth Factor (Egf)-Enhanced Vascular Cell Adhesion Molecule-1 (Vcam-1) Expression Promotes Macrophage and Glioblastoma Cell Interaction and Tumor Cell Invasion

Eukaryotic Extension Factor 2 Kinase may Affect the Occurrence and Development of Glioblastoma Through Immune Cell Infiltration

Up-regulation of EphA2 and down-regulation of EphrinA1 are associated with the aggressive phenotype and poor prognosis of malignant glioma

Epithelial Membrane Protein 1 Promotes Glioblastoma Progression Through the PI3K/AKT/mTOR Signaling Pathway.

EDEM2 is a diagnostic and prognostic biomarker and associated with immune infiltration in glioma: A comprehensive analysis

Human Fibulin-3 Protein Variant Expresses Anti-Cancer Effects in the Malignant Glioma Extracellular Compartment in Intracranial Xenograft Models

EEF1E1 Promotes Glioma Proliferation by Regulating Cell Cycle Through PTEN/AKT Signaling Pathway.

Efemp2 Suppresses Epithelial-Mesenchymal Transition Via Wnt/Beta-Catenin Signaling Pathway In Human Bladder Cancer

Overexpression of Fibrinogen-Like Protein 2 Induces Epithelial-to-mesenchymal Transition and Promotes Tumor Progression in Colorectal Carcinoma

Epidermal growth factor-containing fibulin-like extracellular matrix protein 1 (EFEMP1) suppressed the growth of hepatocellular carcinoma cells by promoting Semaphorin 3B(SEMA3B).

Expression and prognostic role of E2F transcription factors in high-grade glioma

E2F Transcription Factor 8 Promotes Proliferation and Radioresistance in Glioblastoma.